Invuity has reintroduced its PhotonBlade to the market, more than three months after it recalled the minimally invasive surgery light due to “unintended energy discharge” during procedures.
The new and improved PhotonBlade includes what Invuity officials describe as enhancements to improve energy delivery and provide optimized illumination performance. The new PhotonBlade will ship to customers over the next few weeks, the San Francisco–based company announced yesterday.
Before the recall, the device had been out under a limited release; Invuity is now fully launching it commercially.
“We are pleased that PhotonBlade has transitioned to full commercial launch and we look forward to providing our clinicians with this technology to better treat their patients,” Invuity CEO Philip Sawyer said in a news release.
“PhotonBlade exemplifies the company’s strong commitment to providing a broad array of innovative solutions to our customers,” Sawyer said.
PhotonBlade’s novel energy design includes a proprietary insulated blade that Invuity boasts can provide precise cutting and coagulation of tissue with minimal effect on adjacent tissue. The PhotonBlade’s illumination technology does not need a proprietary generator, enabling it to leverage widely available operating room equipment.
Early rates for DeviceTalks Boston end August 15th.
Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.
View Full Agenda
Register today to save. Use code LASTCALL to save an additional 10%.